Led by Tania T. Von Visger, PhD, and Yu-Ping Chang, PhD, the study surveyed 339 adults with COPD. Participants who practice ...

Lung cancer screening populations are older and sicker than those in the National Lung Screening Trial (NLST), a multicenter ...

For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 ...

Respiratory diseases are a challenging problem to treat. Inhalable medicines are a promising solution that depend on the ability to deliver tiny particles known as aerosols to the correct location in ...

A study was undertaken to investigate the associations between RA and type 2 diabetes (DM2), a well-established cardiovascular risk factor, on the one hand, and cardiovascular disease (CVD) on the ...

is widely accepted as a cornerstone of management for people with chronic obstructive pulmonary disease (COPD) and other chronic respiratory disorders.1 The most recent Cochrane review, comprising 65 ...

Chronic obstructive pulmonary disease (COPD) is a group of progressive lung diseases that obstruct airflow. You may experience breathing difficulties, but you can treat and even prevent flare-ups.

Introduction Inhaled gene therapy of muco-obstructive lung diseases requires a strategy to achieve therapeutically ... NK, GK, AL-B, SEB, SMR and JSS prepared the draft of the manuscript. NK, GK, JR, ...

Chronic obstructive pulmonary disease (COPD) is the third-leading cause of death globally ... 10-year incidence was 52% higher than the QRISK3 score predicted (33.5% vs 22.1%). This difference was ...

of obstructive airway disease participants (asthma, chronic obstructive pulmonary disease (COPD) and bronchiectasis) and healthy controls on the basis of nuclear morphology and to assess the ...

The purpose of this meta-analysis was to find additional RTTTs since our 2018 meta-analysis that enrolled subjects with CVD hospitalized for ACS or noncardiac indications comparing liberal versus ...